跳至主要内容
临床试验/CTRI/2021/11/038260
CTRI/2021/11/038260尚未招募未知

Evaluating effect of Escitalopram and Desvenlafaxine on anxiety and BDNF level in depression with comorbid anxiety â?? An open label, randomized, parallel group, clinical study - NI

Dr Chaitali Chindhalore0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Drug naïve patients of either gender having age between 18 to 70 years with a clinical diagnosis of depressive episode as per ICD 10 (F 32)
  • 2.Hamilton Scale of Rating Depression (HAM-D) score >20;
  • 3.Baseline Hamilton Anxiety Rating Scale (HAM-A) score > 14

排除标准

  • 1.Subjects with other coexistent psychiatric disorders as described by ICD 10, (World Health Organization, 2008)
  • 2.Subjects on antianxiety medication within washout period
  • 3.Use of psychoactive substances except tobacco and caffein
  • 4.Concurrent debilitating illnesses like chronic renal failure, malignancy, cirrhosis etc
  • 5.Subjects on drugs which are known to interact with the study medications
  • 6.History of allergy to study medication
  • 7.Lactating and pregnant women

研究者

发起方
Dr Chaitali Chindhalore

相似试验